{"nctId":"NCT01232205","briefTitle":"Antioxidant Supplementation in Pregnant Women","startDateStruct":{"date":"2001-06"},"conditions":["Pregnant Women","Preeclampsia"],"count":168,"armGroups":[{"label":"micronutrient antioxidant","type":"ACTIVE_COMPARATOR","interventionNames":["Dietary Supplement: micronutrient antioxidant"]},{"label":"Control","type":"PLACEBO_COMPARATOR","interventionNames":["Dietary Supplement: Control"]}],"interventions":[{"name":"micronutrient antioxidant","otherNames":["antioxidant"]},{"name":"Control","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* pregnant women with 8-12 weeks of gestation\n\nExclusion Criteria:\n\n* known multiple pregnancy\n* known fetal anomaly\n* known thrombophilia\n* known infections and mola hydatidosa\n* chronic renal failure\n* uncontrolled hypertension\n* known placental abnormalities\n* documented uterine bleeding within a week of screening\n* uterine malformation\n* history of medical and metabolic complication such as heart disease or diabetes","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"20 Years","maximumAge":"40 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Preeclampsia","description":"Preeclampsia was defined as gestational hypertension (systolic pressure ≥140 mmHg or diastolic blood pressure ≥ 90 mmHg \\[Korotkoff V\\] on ≥ 2 occasions after 20 weeks gestation) with proteinuria (\\> 0.3 g/day). Severe preeclampsia was defined by the presence of \\>1 of the following: (a) severe gestational hypertension (systolic pressure ≥160 mmHg or diastolic blood pressure ≥110 mmHg on 2 occasions after gestational week 20), or (b) severe proteinuria (≥5g protein in a 24-h urine specimen or ≥3 g in 2 random urine samples collected ≥4 h apart)","classes":[]},{"type":"SECONDARY","title":"Cell-free mRNA","description":"Secondary outcome were level of mRNA level of angiogenic factors (vascular endothelial growth factor receptor-1 (VEGFR-1), placental growth factor (PlGF) and endoglin(ENG)); antioxidant status (FRAP, heme oksigenase-1 (HO-1) and superoxide-dismutase (SOD))","classes":[]},{"type":"PRIMARY","title":"Preeclampsia","description":"Preeclampsia was defined as gestational hypertension (systolic pressure ≥140 mmHg or diastolic blood pressure ≥ 90 mmHg \\[Korotkoff V\\] on ≥ 2 occasions after 20 weeks gestation) with proteinuria (\\> 0.3 g/day). Severe preeclampsia was defined by the presence of \\>1 of the following: (a) severe gestational hypertension (systolic pressure ≥160 mmHg or diastolic blood pressure ≥110 mmHg on 2 occasions after gestational week 20), or (b) severe proteinuria (≥5g protein in a 24-h urine specimen or ≥3 g in 2 random urine samples collected ≥4 h apart)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}}